Home / World News / Covid-19 crisis: Hydroxychloroquine halted in WHO-funded trials

Covid-19 crisis: Hydroxychloroquine halted in WHO-funded trials

Trump has touted the antimalarial as a treatment for the coronavirus since the early weeks of the global outbreak, calling it a "game-changer," but its prospects have faded

hydroxychloroquine, hcq, drugs, coronavirus, pharma

Premium

US Food and Drug Administration on Monday revoked emergency-use authorization for hydroxychloroquine and chloroquine, a related antimalarial drug, after determining they were unlikely to treat the virus and could have dangerous side effects.

Bloomberg

3 min read Last Updated : Jun 18 2020 | 3:00 AM IST

Tests of hydroxychloroquine, an anti-malaria drug touted by U.S. President Donald Trump, were halted in a World Health Organization trial of potential Covid-19 treatments.

The hydroxychloroquine arm of the WHO’s Solidarity trial was stopped after advisers concluded that the drug shows no benefit compared to the standard of care in reducing deaths, Ana Maria Henao-Restrepo, a WHO medical officer, said Wednesday at a briefing in Geneva.

Trump has touted the antimalarial as a treatment for the coronavirus since the early weeks of the global outbreak, calling it a “game-changer,” but its prospects have faded. US Food and Drug Administration on

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in